{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:28:47Z","timestamp":1790166527155,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajodo.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Orthodontics and Dentofacial Orthopedics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ajodo.2008.08.017","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T06:07:27Z","timestamp":1236319647000},"page":"361-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis"],"prefix":"10.1016","volume":"135","author":[{"given":"James J.","family":"Zahrowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajodo.2008.08.017_bib1","series-title":"Drug facts and comparisons","first-page":"336","year":"2003"},{"key":"10.1016\/j.ajodo.2008.08.017_bib2","first-page":"25","article-title":"The top 200 brand drugs in 2005","volume":"150","author":"Ukens","year":"2006","journal-title":"Drug Topics"},{"key":"10.1016\/j.ajodo.2008.08.017_bib3","series-title":"Harrison's principles of internal medicine","first-page":"2226","article-title":"Osteoporosis","author":"Lindsay","year":"2001"},{"key":"10.1016\/j.ajodo.2008.08.017_bib4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/0003-4819-126-6-199703150-00007","article-title":"The osteoporosis revolution","volume":"126","author":"Raisz","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajodo.2008.08.017_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMcp043801","article-title":"Postmenopausal osteoporosis","volume":"353","author":"Rosen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajodo.2008.08.017_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJMcp042092","article-title":"Screening for osteoporosis","volume":"353","author":"Raisz","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajodo.2008.08.017_bib7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMcp070341","article-title":"Osteopenia","volume":"356","author":"Khosla","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.ajodo.2008.08.017_bib8","first-page":"18","article-title":"Pharmacokinetics of alendronate: an overview","volume":"101","author":"Lin","year":"1999","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ajodo.2008.08.017_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0889-8529(05)70014-1","article-title":"Treatment of osteoporosis with bisphosphonates","volume":"27","author":"Watts","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ajodo.2008.08.017_bib10","series-title":"Prescribing information for Boniva, ibandronate intravenous","year":"2007"},{"key":"10.1016\/j.ajodo.2008.08.017_bib11","series-title":"Prescribing information for Reclast, zoledronic acid intravenous","year":"2007"},{"issue":"12 Suppl","key":"10.1016\/j.ajodo.2008.08.017_bib12","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ajodo.2008.08.017_bib13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development, and therapeutic uses of bisphosphonates","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajodo.2008.08.017_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","article-title":"Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones","volume":"19","author":"Masarachia","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.ajodo.2008.08.017_bib15","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajodo.2008.08.017_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S8756-3282(01)00655-X","volume":"30","author":"Van Beek","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.ajodo.2008.08.017_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of the pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.ajodo.2008.08.017_bib18","first-page":"336","article-title":"Bone turnover in elderly canine mandible and tibia","volume":"76","author":"Dixon","year":"1997","journal-title":"J Dent Res"},{"key":"10.1016\/j.ajodo.2008.08.017_bib19","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1185\/030079904125004475","article-title":"Bone safety of long-term bisphosphonate treatment","volume":"20","author":"Rodan","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajodo.2008.08.017_bib20","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1902\/jop.2004.75.12.1579","article-title":"Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial","volume":"75","author":"Rocha","year":"2004","journal-title":"J Periodontol"},{"issue":"Suppl","key":"10.1016\/j.ajodo.2008.08.017_bib21","first-page":"14","article-title":"The effects of alendronate on bone turnover and bone quality","volume":"101","author":"Meunier","year":"1999","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ajodo.2008.08.017_bib22","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT research group","volume":"85","author":"Black","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajodo.2008.08.017_bib23","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment","volume":"296","author":"Black","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ajodo.2008.08.017_bib24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajodo.2008.08.017_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ajodo.2006.09.035","article-title":"Bisphosphonate treatment: an orthodontic concern calling for a proactive approach","volume":"131","author":"Zahrowski","year":"2007","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1016\/j.ajodo.2008.08.017_bib26","series-title":"Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws","author":"Marx","year":"2007"},{"key":"10.1016\/j.ajodo.2008.08.017_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0889-5406(94)70048-6","article-title":"Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movement in rats","volume":"106","author":"Igarashi","year":"1994","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1016\/j.ajodo.2008.08.017_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajodo.2006.11.002","article-title":"Orthodontic treatment of patients using bisphosphonates: a report of 2 cases","volume":"131","author":"Rinchuse","year":"2007","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1016\/j.ajodo.2008.08.017_bib30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (aredia) and zoledronate (zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws","volume":"65","author":"AAOMS position paper","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib33","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1634\/theoncologist.10-10-842","article-title":"Renal safety and efficacy of I.V. bisphosphonates in patients with skeletal metastases treated for up to 10 years","volume":"10","author":"Guarneri","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.ajodo.2008.08.017_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates (letter)","volume":"353","author":"Durie","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ajodo.2008.08.017_bib36","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.joms.2005.06.003","article-title":"Bisphosphonate-associated osteonecrosis of jaws","volume":"63","author":"Schwarz","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib37","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.joms.2007.04.004","article-title":"Comment on the American Association of Oral Maxillofacial Surgeons statement on bisphosphonates","volume":"65","author":"Zahrowski","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Systemic review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajodo.2008.08.017_bib39","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/01.ASN.0000128955.83129.9C","article-title":"Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin","volume":"15","author":"Lomashvili","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajodo.2008.08.017_bib40","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bone.2005.07.023","article-title":"Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy","volume":"38","author":"Leu","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.ajodo.2008.08.017_bib41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jbmr.5650060915","article-title":"BM21.0955, a potent new bisphosphonate to inhibit bone resorption","volume":"6","author":"Muhlbauer","year":"1991","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.ajodo.2008.08.017_bib42","first-page":"S371","article-title":"Alendronate and risedronate have similar pharmacokinetic half-lives when analyzed over the same time interval","volume":"18","author":"Porras","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajodo.2008.08.017_bib43","series-title":"Prescribing information of Boniva, ibandronate tablets","year":"2006"},{"key":"10.1016\/j.ajodo.2008.08.017_bib44","series-title":"Prescribing information for Actonel, risedronate tablets","year":"2008"},{"key":"10.1016\/j.ajodo.2008.08.017_bib45","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"3","article-title":"Pharmokinetics","author":"Wilkinson","year":"2001"},{"key":"10.1016\/j.ajodo.2008.08.017_bib46","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","article-title":"Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis","volume":"12","author":"Khan","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajodo.2008.08.017_bib47","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMc062792","article-title":"Prolonged bisphosphonate release after treatment in children","volume":"356","author":"Papapoulos","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajodo.2008.08.017_bib48","series-title":"Prescribing information for Fosamax, alendronate tablets","year":"2006"},{"key":"10.1016\/j.ajodo.2008.08.017_bib49","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.14219\/jada.archive.2006.0355","article-title":"ADA report of the Council on Scientific Affairs: dental management of patients receiving oral bisphosphonate therapy\u2014expert panel recommendations","volume":"137","author":"Edwards","year":"2006","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.ajodo.2008.08.017_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib51","first-page":"61","article-title":"Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"JADA"},{"key":"10.1016\/j.ajodo.2008.08.017_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.amjmed.2008.01.047","article-title":"Factors associated with osteonecrosis of the jaw among bisphosphonate users","volume":"121","author":"Hess","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.ajodo.2008.08.017_bib53","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"1649","article-title":"Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of andrenocortical hormones","author":"Schimmer","year":"2001"},{"key":"10.1016\/j.ajodo.2008.08.017_bib54","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajodo.2008.08.017_bib55","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1902\/jop.2007.060514","article-title":"Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and incidence of complications in two private practices","volume":"78","author":"Fugazzotto","year":"2007","journal-title":"J Periodontol"},{"key":"10.1016\/j.ajodo.2008.08.017_bib56","first-page":"349","article-title":"Safety of oral bisphosphonates: controlled studies on alveolar bone","volume":"21","author":"Jeffcoat","year":"2006","journal-title":"Int J Oral Maxillofac Implants"},{"key":"10.1016\/j.ajodo.2008.08.017_bib57","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1902\/jop.2007.060239","article-title":"Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report","volume":"78","author":"Wang","year":"2007","journal-title":"J Periodontol"},{"key":"10.1016\/j.ajodo.2008.08.017_bib58","first-page":"74","article-title":"Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report","volume":"10","author":"Starck","year":"1995","journal-title":"Int J Oral Maxillofac Implants"},{"key":"10.1016\/j.ajodo.2008.08.017_bib59","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajodo.2008.08.017_bib60","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.14219\/jada.archive.2005.0109","article-title":"Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge","volume":"136","author":"Markewicz","year":"2005","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.ajodo.2008.08.017_bib61","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jbmr.5650061110","article-title":"Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants","volume":"6","author":"van der Pluijm","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajodo.2008.08.017_bib62","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","article-title":"Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]","volume":"65","author":"Harper","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMp038103","article-title":"Do bisphosphonates make children's bones better or brittle?","volume":"349","author":"Marini","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajodo.2008.08.017_bib64","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1177\/00220345960750090501","article-title":"Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats","volume":"75","author":"Igarashi","year":"1996","journal-title":"J Dent Res"},{"key":"10.1016\/j.ajodo.2008.08.017_bib65","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","article-title":"Bisphosphonates act on rat bone resorption through the mediation of osteoblasts","volume":"91","author":"Sahni","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajodo.2008.08.017_bib66","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joms.2008.02.012","article-title":"Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?","volume":"66","author":"Junquera","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ajodo.2008.08.017_bib67","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2214\/AJR.07.3045","article-title":"MRI of mandibular osteonecrosis secondary to bisphosphonates","volume":"190","author":"Garcia-Ferrer","year":"2008","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ajodo.2008.08.017_bib68","first-page":"1629","article-title":"Bone scanning of limited value for diagnosis of symptomatic oligofocal and multifocal osteonecrosis","volume":"35","author":"Mont","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajodo.2008.08.017_bib69","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"}],"container-title":["American Journal of Orthodontics and Dentofacial Orthopedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088954060801192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088954060801192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:47:37Z","timestamp":1760172457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088954060801192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S088954060801192X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajodo.2008.08.017","relation":{},"ISSN":["0889-5406"],"issn-type":[{"value":"0889-5406","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Orthodontics and Dentofacial Orthopedics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajodo.2008.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}